The document discusses the global injectable generic drug market. It focuses on sterile drugs delivered via injection or infusion that treat major illnesses like cancer, central nervous system disorders, acute cardiovascular conditions, and severe infections. The largest markets are the US, Germany, and UK. The FDA approved 391 generic injectable drugs between 2003-2008, with the most in oncology, anti-infectives, and central nervous system conditions. The top companies receiving ANDA approvals for injectables during this period were Bedford Laboratories, APP Pharmaceuticals, Teva, Hospira, and Sandoz.

1. Global Injectable Generic Drug Market Ritupon Gogoi, B.Pharm, MBA

7. FDA ANDA Approvals by Company 2003-2008 Number of approved ANDAs